Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Convertible Debentures $200,000 CAD
View:
Post by LithLover on Aug 23, 2022 2:15pm

Convertible Debentures $200,000 CAD

The news release was in USD.  Hence the $177,000 amount.  The total is $200,000 CAD for those wondering why it was such a strange amount.

“Offering” means private placement pursuant to which the Corporation will issue up to 200 units, each of which is comprised of (i) $1,000 in principal amount of 8% unsecured convertible debentures, and (ii) 9,090 common share purchase warrants, up to an aggregate value of CAD$200,000;


Cash on hand June 30, 2022 $90,626.

Expenses for Q2: $1,191,935 or $639,978 per month or $21,000 per day.
Comment by Liked2Think on Aug 23, 2022 2:48pm
Its nice to think they dont need anymore money but that doesnt fly with what Tripp said in the CC about throwing more money at marketing to do this. So how do you know the $200k is because they dont need anymore rather than it only being $200K because thats all they could get? There is no proof that backs up one way or the other.
Comment by LithLover on Aug 23, 2022 3:20pm
From Dec 2021 to March 2022 cash ending balances were $1,724,724 to $609,212 with a $1.87 million PP in Feb/March.   Cash used $2,985,512 From March 2022 to June 2022 the cash ending balances were $609,212 to $90,626.  No financing, cash used $518,593. June cash ending $90,626 with financing of $200,000.  2 months almost gone out of the 3 month quarter and lokks like cash ...more  
Comment by Mykndrsn on Aug 23, 2022 6:31pm
This is waaaaaay over L2T's head. He can barely count. 
Comment by Liked2Think on Aug 24, 2022 9:09am
so you see nothing wrong with spending 1.2M less but only making $100K more? To me it just looks like they were spending like no tomorrow, realized they werent making enough money and have been in cost cutting mode even though they admit you need to spend money to get this thing to work and market it. you have no idea if the company is cash flow positive or close to it. you would have no way of ...more  
Comment by NewToInvesting7 on Aug 27, 2022 10:59am
Absolutely nothing wrong with spending $1.2m less and 'only' making $100k of additional revenues.  That's a net +$1.3m to net income.  And for a company that's as small as StageZero, a company that currently generates such a small amount of revenues, that a massive change. I doubt the company is cash flow positive.  Can't see it being so until mid-late 2023 the ...more  
Comment by Mykndrsn on Aug 27, 2022 3:31pm
You're new here. Replying to L2T is like having an intelligent conversation with your goldfish.
Comment by Liked2Think on Aug 27, 2022 7:29pm
Goldfish is smart too meanie head   quote=Mykndrsn]You're new here. Replying to L2T is like having an intelligent conversation with your goldfish. [/quote]  
Comment by 4real4ever on Aug 23, 2022 7:27pm
Now I understand why they didn't told any numbers about Aristotle's sale it's because they make too much money   Same reason why they did a low financing of $177k they make to much money        
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities